A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Acalabrutinib Impurity 43 - Request Quote

Picture of Acalabrutinib Impurity 43

Acalabrutinib Impurity 43

SZ CAT No:SZ-A078075
CAS No
NA
Mol.F.
C26H24BrN7O2
Mol.Wt.
546.4
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Acalabrutinib Impurity 43 is chemically (S,Z)-4-(8-amino-3-(1-(3-bromobut-2-enoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide. Acalabrutinib Impurity 43 is supplied with detailed characterization data compliant with regulatory guideline. Acalabrutinib Impurity 43 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Acalabrutinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Acalabrutinib Impurity 43

Purchase Acalabrutinib Impurity 43

Acalabrutinib Impurity 43 suppliers

Acalabrutinib Impurity 43 manufacturers

Acalabrutinib Impurity 43 price

Order Acalabrutinib Impurity 43

Enquire Acalabrutinib Impurity 43

Acalabrutinib Impurity 43 cost

Acalabrutinib Impurity 43 Supplier

Acalabrutinib Impurity 43 Distributor

Acalabrutinib Impurity 43 for Method Validation

Acalabrutinib Reference Standard

Acalabrutinib Impurity 43 for ANDA Filing

Acalabrutinib Impurity 43 for Forced Degradation Studies

Acalabrutinib Impurity 43 Identification Standards

Acalabrutinib Impurity 43 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,